Propyl Gallate: A Comprehensive Encyclopedic Reference
1. Identity: Chemical Names, Origin, and Physical Characteristics
1.1 Chemical Names and Identifiers
Propyl gallate, or propyl 3,4,5-trihydroxybenzoate, is an ester formed by the condensation of gallic acid and propanol. Its systematic and trade names include: Benzoic acid, 3,4,5-trihydroxy-, propyl ester; Gallic acid, propyl ester; n-Propyl gallate; n-Propyl 3,4,5-trihydroxybenzoate; Nipagallin P; Progallin P; Tenox PG; and NCI-C505888, among others. Codex GSFA identifies it as additive 310 and classifies it as an antioxidant, while PubChem records it under formula C10H12O5. In food additive systems, propyl gallate is identified as INS 310 and commonly referred to as E310 in many markets.
1.2 Physical Properties
Propyl gallate (PG) is a white to nearly white odorless crystalline powder that has a slightly bitter taste and darkens in the presence of iron salts. PG is markedly hydrophilic, so its solubility in fats is limited; substitution of the propyl chain by a shorter (ethyl) or longer (octyl or dodecyl) chain, respectively, decreases or increases fat solubility.
1.3 Synthesis and Manufacturing
Propyl gallate does not occur naturally and is prepared either from reactions with gallic acid and 1-propanol, or by enzyme catalysis of tannic acid. Syntheses with gallic acid have been the most prominent methods of production, and include Steglich esterification with N,N'-diisopropylcarbodiimide and 4-dimethylaminopyridine, anhydrous addition of thionyl chloride, and Fischer esterification with various catalysts. It is commercially prepared by esterification of gallic acid with propyl alcohol followed by distillation to remove excess alcohol.
1.4 Relationship to Natural Gallic Acid and Tannins
Although propyl gallate itself is not found in nature, its parent compound gallic acid is widely distributed throughout the plant kingdom. Gallic acid (GA; 3,4,5-trihydroxy benzoic acid), as the core structure of PG, is a polyphenolic antioxidant naturally generated in fruits, plants, and plant parts such as tea leaves, evening primrose, bearberry leaf, blueberries, and walnuts. Gallic acid is found in gallnuts, sumac, witch hazel, tea leaves, oak bark, and other plants. Synthetic gallic acid is produced through alkaline and acid hydrolysis of tannins (gallotannin or taratannin) from gallnuts and synthesized from phenylalanine via trihydroxycinnamic acid or caffeic acid. Salts and esters of gallic acid are termed "gallates," and the name derives from oak galls, which were historically used to prepare tannic acid. Gallate esters are antioxidants useful in food preservation, with propyl gallate being the most commonly used.
1.5 Common Forms and Preparations
PG is used to stabilize cosmetics, food packaging materials, and foods including edible fats, oils, mayonnaise and other emulsions, shortening, baked goods, candy, dried meat, fresh pork, sausage, and dried milk. Propyl gallate is used to protect oils and fats in products from oxidation; it is used in foods, cosmetics, hair products, adhesives, biodiesel, and lubricants. It is often used interchangeably with octyl gallate and dodecyl gallate in these applications. In pharmaceutical contexts, it functions as an excipient antioxidant to stabilize lipid-containing preparations.
2. Traditional and Historical Use
2.1 History of Gallic Acid-Rich Plants in Traditional Medicine
Propyl gallate itself has no traditional medicinal history, as it is a synthetic compound introduced in the mid-20th century. However, its precursor compound, gallic acid, and the tannin-rich plant sources from which it derives have extensive documented use across multiple traditional medical systems. Propyl gallate is a synthetic antioxidant derived from gallic acid; gallic acid itself is a component found in a variety of plants such as gallnuts, sumac, witch hazel, tea leaves, and oak bark, which have historically been used in traditional medicine across cultures, prized for their natural astringent, anti-inflammatory, and antimicrobial properties. Remedies containing gallates were applied to soothe wounds, reduce swelling, and treat infections, reflecting the broad therapeutic value attributed to these compounds.
Gallic acid and its derivatives as they occur in extracts of oak-galls constitute a chemical reagent of considerable antiquity; the blue-black color produced when an aqueous infusion is treated with salts of iron was first described by Pliny. This reaction underpinned the use of gall extracts in ink-making and analytical chemistry for centuries.
2.2 Introduction and Adoption of Propyl Gallate as an Industrial Additive
Since 1948, this antioxidant has been added to foods containing oils and fats to prevent oxidation. It has been used since 1948 to stabilize cosmetic and food-packaging materials, and foods containing fats, and as an additive in edible fats, oils, mayonnaise, shortening, baked products, pressure-sensitive adhesives, lubricating oil additives, and transforming oils. PG has been used as an antioxidant in food, cosmetics, and medicine for over 70 years. In the early 20th century, the isolation and synthesis of propyl gallate allowed for more controlled and concentrated applications.
3. Key Constituents, Active Compounds, and Mechanisms of Action
3.1 Structural Basis of Antioxidant Activity
Propyl gallate (E310) is a phenolic antioxidant extensively used in the food, cosmetics, and pharmaceutical industries. Its biological activity arises from the trihydroxyphenolic (pyrogallol) ring of gallic acid, which provides three phenolic hydroxyl groups capable of donating hydrogen atoms to reactive free radicals.
An OH-group of propyl gallate can donate a hydrogen atom plus a free electron to the unpaired electron of a reactive free radical, resulting in its neutralization and inactivation. The other free electron of propyl gallate enters the circular flow of electrons within the chemical's ring structure, making the antioxidant itself a non-reactive free radical. When a free radical encounters propyl gallate, the radical abstracts a hydrogen atom from one of the phenolic hydroxyl groups, forming a more stable phenoxyl radical, which is less reactive due to resonance stabilization. The formation of this phenoxyl radical is key to stopping the propagation phase of lipid peroxidation, a common oxidative process in food spoilage and cellular damage.
3.2 Hydrogen Transfer vs. Electron Transfer Mechanisms
Three reaction mechanisms have been studied: hydrogen transfer (HT), radical adduct formation (RAF), and single electron transfer (SET). Rate constants and relative branching ratios for the different paths have been reported. Propyl gallate reacts mainly through the HT mechanism, independently of the solvent or the peroxyl radical, contrary to other phenols such as catechols and guayacols, which react mainly via the SET mechanism. In aqueous media at physiological pH, the calculated rate constants towards the ˙OOH, ˙OOCH3 and ˙OOCHCH2 radicals are 4.56 × 10⁸, 1.59 × 10⁶ and 4.05 × 10⁸ M⁻¹ s⁻¹, while in lipid media the rate constants are 2.94 × 10⁴, 7.73 × 10³ and 9.94 × 10⁵ M⁻¹ s⁻¹; thus, a propyl gallate molecule acts as a very efficient peroxyl radical scavenger, both in aqueous and lipid media.
3.3 Metal Chelation
In addition to direct radical scavenging, propyl gallate exerts antioxidant effects through metal ion chelation. Propyl gallate exhibits metal ion chelation of ions such as iron and copper, which can act as catalysts for oxidation reactions, accelerating the formation of free radicals. By binding to these metal ions, propyl gallate reduces their catalytic activity, thereby further inhibiting the oxidation process. This dual action — radical scavenging and metal chelation — makes it a highly effective antioxidant.
3.4 Chain-Breaking Antioxidant in Lipid Peroxidation
As an antioxidant, propyl gallate prevents the formation or accumulation of free radicals in a chemical or biological system — hence its description as a "free-radical scavenger." Free radicals can be generated in these systems by irradiation, chemical reaction, oxidation, or enzymatic reactions. Propyl gallate is often used to prevent the free-radical peroxidation of lipids. One molecule of alkyl gallate, regardless of alkyl chain length, scavenges six molecules of 1,1-diphenyl-2-picrylhydrazyl (DPPH). Alkyl gallates inhibited the linoleic acid peroxidation catalyzed by soybean lipoxygenase-1 without being oxidized.
3.5 Synergism with Other Antioxidants
The antioxidant activity of PG is synergistic with acids, BHA, and BHT. This synergism is exploited extensively in industrial food formulations, where combinations of antioxidants extend shelf life more effectively than any single compound alone.
3.6 Metabolic Fate: Conversion to Gallic Acid and Pyrogallol
The metabolic profile of propyl gallate is critical to understanding both its therapeutic potential and its toxicological concerns. A central focus of recent research is PG's metabolic fate: PG is rapidly and extensively hydrolyzed to gallic acid (GA) upon ingestion. This review delineates the critical metabolic cascade transforming propyl gallate into gallic acid via liver hydrolysis, and subsequently into pyrogallol through gut microbiota decarboxylation. Metabolic fates of PG are similar in rats, pigs, and humans. Non-oxidative pathways such as O-methylation, decarboxylation, and conjugation with sulfate and glucuronic acid are significant reactions in the gallate's metabolism. Gallic acid is converted to 4-O-methyl gallic acid by O-methylation, glucuronidated and excreted via urine. Propyl alcohol is incorporated into intermediate metabolism of the individual.
The metabolic process involves hydrolysis of PG into GA and n-propanol after ingestion. GA is the primary metabolite that exhibits various bioactive effects. The secondary conversion of GA to pyrogallol (PY) by gut microbiota is considered the most toxicologically significant step. The conversion of GA to PY by gut microbiota represents the most critical step in the toxicological cascade. PY is a potent reducing agent that readily auto-oxidizes, generating superoxide anions and other ROS.
4. Scientific Evidence by Area of Use
4.1 Antioxidant Activity and Lipid Oxidation Inhibition
The best-established evidence for propyl gallate concerns its antioxidant function in food matrices. Propyl gallate is an antioxidant widely used to preserve and stabilize the freshness, nutritional value, flavor, and color of foods, fats and oils, and medicinal preparations. Its primary function is to inhibit the autoxidation of lipids, thereby extending the shelf life and maintaining the quality of products rich in fats and oils. By scavenging free radicals, PG effectively interrupts the chain reactions that lead to rancidity, preserving flavor, aroma, and nutritional value.
Evidence strength: The antioxidant efficacy of propyl gallate in food systems is exceptionally well-documented by decades of industrial and regulatory use, multiple in vitro studies, and corroborated by theoretical computational chemistry. This constitutes the strongest and most reproducible body of evidence for propyl gallate.
4.2 Neuroprotection
Several preclinical studies have explored whether propyl gallate's antioxidant properties translate into neuroprotective effects.
One study was conducted to assess the effects of intraperitoneal administration of n-propyl gallate (PG) on hippocampal neuronal survival after forebrain ischemia in rats. The results indicated that intraperitoneal administration of PG may have neuroprotective effects in a model of moderate, but not severe, forebrain ischemia in rats. Forty male Sprague-Dawley rats were randomly assigned to one of six groups; animals in the PG groups received intraperitoneal injection of PG (100 mg/kg) at 72, 48, 24 hours, and 30 minutes before severe (10 min) or moderate (8 min) ischemia.
A more recent animal study investigated propyl gallate in the context of Alzheimer's-like neurodegeneration. This study investigated the neuroprotective effects of PG, a phenolic antioxidant widely used as a food additive, against methylglyoxal (MG)-induced cognitive impairment in mice. Male C57BL/6J mice were exposed to 1% MG in drinking water for eight weeks and orally administered PG (20, 40, or 100 mg/kg/d). Behavioral tests demonstrated that PG significantly improved spatial learning and recognition memory and alleviated anxiety-like behavior. Histological and biochemical analyses revealed that PG reduced hippocampal neuronal damage, suppressed tau hyperphosphorylation and amyloid-β (Aβ) accumulation, and attenuated the overexpression of pro-inflammatory cytokines TNF-α and IL-6. Furthermore, PG increased PI3K expression and Akt phosphorylation while reducing activation of GSK-3β.
A 2025 rodent study examined propyl gallate in the context of chronic sleep deprivation. PG, a lipophilic ester of gallic acid with established antioxidant activity, was investigated in the context of prolonged sleep deprivation. Male ICR mice were subjected to 14 days of chronic sleep deprivation (CSD) using a rolling-drum apparatus and received oral PG (50, 100, or 200 mg/kg) or Ginkgo biloba extract (GBE, 40 mg/kg). Oxidative and inflammatory biomarkers were assessed in serum and hippocampus, and Western blotting quantified the expression of Nrf2, HO-1, NQO1, NF-κB, iNOS, and COX2, establishing a scientific foundation for its potential use as a neuroprotective polyphenol.
PG has been reported to be an effective antioxidant-based hepatoprotector and has been shown to prevent neuronal apoptosis.
Evidence strength: All neuroprotection evidence is preclinical (animal and cell-based models). No human clinical trials have assessed propyl gallate for neuroprotective outcomes. This area of research is preliminary and cannot currently be translated to therapeutic claims in humans.
4.3 Anticancer Activity
The poor prognosis of hepatocellular carcinoma (HCC) has been attributed to a high frequency of tumor metastasis and recurrence. Propyl gallate, a synthetic antioxidant used in preserving food and medicinal preparations, has been shown to induce cancer cell death; in one study, PG inhibited HCC cell proliferation in vitro and in zebrafish models in vivo in a dose- and time-dependent manner. PG also induced cell apoptosis and increased the number of necrotic cells in a time- and dose-dependent manner. PG also increased the intracellular levels of superoxide and reactive oxidative stress as well as the formation of autophagosomes and lysosomes.
Propyl gallate has antioxidant property, free radical scavenging effects, antitumor and mutagenesis prevention activity. Over the last few decades, a large number of publications have reported antioxidative, anti-apoptotic, cardioprotective, neuroprotective, and anticancer properties of gallic acid and gallates, mostly demonstrating their antioxidative or prooxidative properties influencing ROS signaling networks. However, very little focus has been paid on clinical trials, and this has restricted their use as a prescribed preventative supplement.
Evidence strength: Anticancer evidence for propyl gallate is entirely preclinical — limited to in vitro cell lines and animal (including zebrafish) models. No human clinical trials have been conducted. The paradoxical pro-oxidant activity at high doses that underlies cancer cell death may differ fundamentally from the compound's behavior at dietary exposure levels.
4.4 Antimicrobial Properties
In addition to antioxidant properties, PG has been reported to show antimicrobial effects. Beyond its primary function as an antioxidant, recent studies have highlighted its antimicrobial properties, adding to its versatility in various applications.
Evidence strength: Antimicrobial effects have been documented primarily in vitro. The extent to which these effects translate to meaningful antimicrobial activity under physiological conditions or at food-additive concentrations is not well-characterized by clinical evidence.
4.5 Hepatoprotective Properties
PG has been reported to be an effective antioxidant-based hepatoprotector. These findings are based on preclinical studies where PG's free-radical scavenging and anti-lipid peroxidation activity appears to protect liver cells from oxidative injury. The proposed mechanism is consistent with PG's well-documented ability to inhibit lipid peroxidation and reduce ROS generation. However, as with neuroprotection and anticancer effects, no clinical trials in humans have validated this application.
Evidence strength: Preclinical only. The hepatoprotective claims require confirmation in human studies.
4.6 Tyrosinase Inhibition
Propyl gallate is a known inhibitor of tyrosinase, a polyphenol oxidase, which is an important enzyme in pigment biosynthesis in various organisms. This property has implications for skin-lightening applications in cosmetics, though clinical efficacy data in humans remain limited.
5. Body Systems and Health Areas
- Oxidative Stress / Antioxidant Defense: PG effectively interrupts chain reactions leading to rancidity and is the subject of an evolving scientific narrative reframing it from a simple preservative to a multifaceted bioactive compound.
- Nervous System: PG has been shown in animal models to protect against methylglyoxal-related cognitive dysfunction through modulation of neuroinflammatory responses and survival-related signaling pathways.
- Hepatic / Liver: PG has been reported to be an effective antioxidant-based hepatoprotector in preclinical literature.
- Oncology (preclinical): ROS production in mitochondria induces programmed cell death, functioning in an upstream apoptotic pathway; PG inhibits HCC cell proliferation through the regulation of apoptosis-related signaling pathways.
- Endocrine System (concern): Using proliferation tests and gene reporter assays, propyl gallate was found to behave as either estrogenic or anti-oestrogenic compound both alone or in binary mixtures with BHA, BHT, or butylparaben; the available data do not allow a conclusion on a dose relationship between propyl gallate and its pro- and/or anti-oestrogenic activity.
- Skin / Dermatology: Propyl gallate is an irritant that can cause skin dryness, dermatitis, and sensitization.
6. Dosage Forms and Dosages Reported in Studies
6.1 Regulatory Permitted Use Levels in Food
According to 21 CFR 184.1660, propyl gallate is generally recognized as safe (GRAS) for use in food as an antioxidant. The FDA has placed the limit on the total antioxidant content (including propyl gallate) of food at 0.02% of the fat or oil content of the food (21 CFR 582.3660). In the European Union, propyl gallate is authorized for use in food as an antioxidant up to a maximum level of 400 mg/kg.
6.2 Acceptable Daily Intake (ADI)
Based on a NOAEL of 135 mg propyl gallate/kg bw/day from a key subchronic study, and applying an uncertainty factor of 300 for extrapolation from subchronic to chronic data and due to limitations in the reproductive toxicity database, EFSA derived an ADI of 0.5 mg/kg bw/day for propyl gallate. The Joint FAO/WHO Expert Committee on Food Additives (JECFA) has set an ADI for propyl gallate of 1.4 mg/kg bw per day based on a NOAEL of 1,910 mg/kg feed (equivalent to 135 mg/kg bw per day) derived from a 90-day toxicity study in rats.
6.3 Cosmetic Use Concentrations
According to regulatory submissions and a 2024 CIR survey, propyl gallate is used in cosmetics at up to 0.2% in leave-on face, neck, and moisturizing products. The Cosmetic Ingredient Review (CIR) Expert Panel has concluded it is safe for use in cosmetics at concentrations up to 0.1%.
6.4 Preclinical Research Dosages
The following dosages have been reported in preclinical studies, and are provided strictly as noted in those publications. They do not represent recommended human dosages:
- In a rat forebrain ischemia study, animals received intraperitoneal injection of PG at 100 mg/kg at 72, 48, 24 hours, and 30 minutes before ischemic procedure.
- In a methylglyoxal-induced Alzheimer's-like mouse model, PG was orally administered at 20, 40, or 100 mg/kg/d for eight weeks.
- In a chronic sleep deprivation mouse study, oral PG was administered at 50, 100, or 200 mg/kg daily for 14 days.
7. Safety Considerations and Interactions
7.1 Regulatory Safety Status
EFSA has evaluated the use of PG in the food industry, establishing an ADI of 0.5 mg/kg bw per day and concluding that, based on exposure assessment, at the current level of use, PG is not of safety concern. The high level of exposure exceeded the ADI in adults and the elderly in conservative exposure modelling; however, given the conservatism of the exposure assessment, the Panel concluded that the use of propyl gallate as a food additive at the current uses and use levels is not of safety concern.
Acute toxicity studies exist in different species for propyl gallate, which had low, if any, acute toxicity. The EFSA Panel considered that no substantial new toxicological data had emerged since the last JECFA evaluation, and concluded that the 90-day toxicity study in rats was the key study for evaluation, given the uncertainties and lack of a NOAEL in the carcinogenicity database on propyl gallate.
7.2 Endocrine Disruption
Using proliferation tests and gene reporter assays, propyl gallate was found to behave as either estrogenic or anti-oestrogenic compound — in the presence of estradiol (E2) — both alone or in binary mixtures with BHA, BHT, or butylparaben, thereby confirming its endocrine disrupting properties. The available data do not allow the EFSA FEEDAP Panel to conclude on a dose relationship between propyl gallate and its pro- and/or anti-oestrogenic activity. It may also interfere with normal thyroid function. The clinical significance of these findings at typical food-additive exposure levels remains uncertain and is an area of active regulatory scrutiny.
7.3 Genotoxicity
Propyl gallate was weakly positive in bacterial reverse mutation assays on the strain TA 102 of Salmonella typhimurium, which is sensitive to oxidizing mutagens, and negative in all other strains. Clastogenic activity was reported in three out of four in vitro cytogenetic studies. The substance was negative in two in vivo studies: a chromosome aberrations assay in rat bone marrow after oral administration and a micronucleus assay in mouse bone marrow after intraperitoneal administration. This metabolic context clarifies the historical discrepancy between in vitro genotoxicity, driven by reactive oxygen species (ROS) generation, and its general lack of in vivo genotoxicity.
7.4 Carcinogenicity Concerns
Studies from the National Toxicology Program reported that long-term exposure to propyl gallate caused some mice and rats to develop tumors, though the link to cancer needs further research. The EFSA Panel has noted the lack of a clear NOAEL in the carcinogenicity database, and this data gap was a primary reason for applying a large uncertainty factor (300) when deriving the ADI.
7.5 Metabolite Toxicity (Pyrogallol)
The secondary metabolite pyrogallol (PY) poses a distinct toxicological concern that is separate from propyl gallate itself. The conversion of GA to PY by gut microbiota represents the most critical step in the toxicological cascade. PY is a potent reducing agent that readily auto-oxidizes, generating superoxide anions and other ROS. The significance of this pathway depends on microbial composition and overall dose.
7.6 Skin Sensitization and Dermal Reactions
Propyl gallate is an irritant that can cause skin dryness, dermatitis, and sensitization. Propyl gallate has been associated with allergic reactions, including contact dermatitis and hypersensitivity, particularly in individuals with pre-existing sensitivities. These reactions are rare but may occur in products containing high concentrations of the additive.
7.7 Inhalation Risk
Inhalation of propyl gallate may cause chemical pneumonia. This risk is relevant primarily in occupational settings involving handling of the bulk powder.
7.8 Interaction with Iron Salts
Propyl gallate darkens in the presence of iron salts. This property reflects its iron-chelating mechanism and is also a practical stability consideration: the compound can form dark-colored complexes with metal ions present in some food matrices or cookware, potentially affecting product appearance.
7.9 Synergistic Formulation Interactions
The antioxidant activity of PG is synergistic with chelating acids, BHA, and BHT. This synergism means propyl gallate is frequently co-formulated with these agents, and the combined endocrine-disruptive potential of such mixtures has been noted in regulatory reviews. Using proliferation tests and gene reporter assays, propyl gallate was found to behave as either estrogenic or anti-oestrogenic compound in binary mixtures with BHA, BHT, or butylparaben.
7.10 Population-Specific Considerations
The ADI for food additives applies to the general population, except for infants below 16 weeks. EFSA has not established a separate ADI for this age group due to insufficient data, representing a gap in the safety assessment.
References
Go back